Biotech

All Articles

BioMarin builds director team along with biotech vets-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings and ...

Biopharma Q2 VC hit highest level since '22, while M&ampA slowed

.Financial backing backing into biopharma rose to $9.2 billion across 215 sell the 2nd fourth of the...

Bicara, Zenas find IPOs to press late-phase assets towards market

.Bicara Rehabs and also Zenas Biopharma have actually delivered clean motivation to the IPO market a...

Genentech to close cancer immunology analysis department

.Genentech will definitely close its cancer cells immunology research department, and also unit head...

Kezar drops strong growth but to prove its really worth in stage 1 test

.Kezar Life Sciences is dropping its own unpromising phase 1 solid growth medication as the biotech ...

Acelyrin loses izokibep, lets go 3rd of team

.In spite of izokibep maintaining its own newly found winning streak in the clinic, Acelyrin is actu...

Rivus' period 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its fat-busting, muscle-sparing medi...

Ovid halts preclinical job, IV plan after soticlestat stop working

.Ovid Therapy currently disclosed last month that it was trimming its head count as the firm gets th...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened up a $700 million R&ampD center in the Boston ma Seaport, improving its RNA an...

Boundless Bio produces 'modest' layoffs five months after $100M IPO

.Just 5 months after protecting a $one hundred thousand IPO, Limitless Bio is actually laying off so...